Global Genitourinary Drugs Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 27-Jul-2020
No. of pages: 98
Inquire Before Buying

Genitourinary Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genitourinary Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

- Novartis AG

- Genentech

- ...

Market segment by Type, the product can be split into

- Urologicals

- Hormonal Therapy

- Gynecological

- Anti-infectives

Market segment by Application, split into

- Prostate Cancer

- Ovarian Cancer

- Bladder Cancer

- Cervical Cancer

- Renal Cancer

- Erectile Dysfunction

- Urinary Tract Infections

- Urinary Incontinence & Overactive Bladder

- Sexually Transmitted Diseases

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

Global Genitourinary Drugs Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genitourinary Drugs Revenue
1.4 Market by Type
1.4.1 Global Genitourinary Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Urologicals
1.4.3 Hormonal Therapy
1.4.4 Gynecological
1.4.5 Anti-infectives
1.5 Market by Application
1.5.1 Global Genitourinary Drugs Market Share by Application: 2020 VS 2026
1.5.2 Prostate Cancer
1.5.3 Ovarian Cancer
1.5.4 Bladder Cancer
1.5.5 Cervical Cancer
1.5.6 Renal Cancer
1.5.7 Erectile Dysfunction
1.5.8 Urinary Tract Infections
1.5.9 Urinary Incontinence & Overactive Bladder
1.5.10 Sexually Transmitted Diseases
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Genitourinary Drugs Market Perspective (2015-2026)
2.2 Global Genitourinary Drugs Growth Trends by Regions
2.2.1 Genitourinary Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genitourinary Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Genitourinary Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Genitourinary Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Genitourinary Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Genitourinary Drugs Players by Market Size
3.1.1 Global Top Genitourinary Drugs Players by Revenue (2015-2020)
3.1.2 Global Genitourinary Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genitourinary Drugs Market Concentration Ratio
3.2.1 Global Genitourinary Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genitourinary Drugs Revenue in 2019
3.3 Genitourinary Drugs Key Players Head office and Area Served
3.4 Key Players Genitourinary Drugs Product Solution and Service
3.5 Date of Enter into Genitourinary Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Genitourinary Drugs Historic Market Size by Type (2015-2020)
4.2 Global Genitourinary Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Genitourinary Drugs Market Size by Application (2015-2020)
5.2 Global Genitourinary Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Genitourinary Drugs Market Size (2015-2020)
6.2 Genitourinary Drugs Key Players in North America (2019-2020)
6.3 North America Genitourinary Drugs Market Size by Type (2015-2020)
6.4 North America Genitourinary Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Genitourinary Drugs Market Size (2015-2020)
7.2 Genitourinary Drugs Key Players in Europe (2019-2020)
7.3 Europe Genitourinary Drugs Market Size by Type (2015-2020)
7.4 Europe Genitourinary Drugs Market Size by Application (2015-2020)
8 China
8.1 China Genitourinary Drugs Market Size (2015-2020)
8.2 Genitourinary Drugs Key Players in China (2019-2020)
8.3 China Genitourinary Drugs Market Size by Type (2015-2020)
8.4 China Genitourinary Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Genitourinary Drugs Market Size (2015-2020)
9.2 Genitourinary Drugs Key Players in Japan (2019-2020)
9.3 Japan Genitourinary Drugs Market Size by Type (2015-2020)
9.4 Japan Genitourinary Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Genitourinary Drugs Market Size (2015-2020)
10.2 Genitourinary Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genitourinary Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Genitourinary Drugs Market Size by Application (2015-2020)
11 India
11.1 India Genitourinary Drugs Market Size (2015-2020)
11.2 Genitourinary Drugs Key Players in India (2019-2020)
11.3 India Genitourinary Drugs Market Size by Type (2015-2020)
11.4 India Genitourinary Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Genitourinary Drugs Market Size (2015-2020)
12.2 Genitourinary Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Genitourinary Drugs Market Size by Type (2015-2020)
12.4 Central & South America Genitourinary Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis AG
13.1.1 Novartis AG Company Details
13.1.2 Novartis AG Business Overview
13.1.3 Novartis AG Genitourinary Drugs Introduction
13.1.4 Novartis AG Revenue in Genitourinary Drugs Business (2015-2020))
13.1.5 Novartis AG Recent Development
13.2 Genentech
13.2.1 Genentech Company Details
13.2.2 Genentech Business Overview
13.2.3 Genentech Genitourinary Drugs Introduction
13.2.4 Genentech Revenue in Genitourinary Drugs Business (2015-2020)
13.2.5 Genentech Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Genitourinary Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Genitourinary Drugs Revenue
Table 3. Ranking of Global Top Genitourinary Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Genitourinary Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Urologicals
Table 6. Key Players of Hormonal Therapy
Table 7. Key Players of Gynecological
Table 8. Key Players of Anti-infectives
Table 9. Global Genitourinary Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Genitourinary Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Genitourinary Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Genitourinary Drugs Market Share by Regions (2015-2020)
Table 13. Global Genitourinary Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Genitourinary Drugs Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Genitourinary Drugs Market Growth Strategy
Table 19. Main Points Interviewed from Key Genitourinary Drugs Players
Table 20. Global Genitourinary Drugs Revenue by Players (2015-2020) (Million US$)
Table 21. Global Genitourinary Drugs Market Share by Players (2015-2020)
Table 22. Global Top Genitourinary Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genitourinary Drugs as of 2019)
Table 23. Global Genitourinary Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Genitourinary Drugs Product Solution and Service
Table 26. Date of Enter into Genitourinary Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 29. Global Genitourinary Drugs Market Size Share by Type (2015-2020)
Table 30. Global Genitourinary Drugs Revenue Market Share by Type (2021-2026)
Table 31. Global Genitourinary Drugs Market Size Share by Application (2015-2020)
Table 32. Global Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 33. Global Genitourinary Drugs Market Size Share by Application (2021-2026)
Table 34. North America Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Genitourinary Drugs Market Share (2019-2020)
Table 36. North America Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 37. North America Genitourinary Drugs Market Share by Type (2015-2020)
Table 38. North America Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. North America Genitourinary Drugs Market Share by Application (2015-2020)
Table 40. Europe Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Genitourinary Drugs Market Share (2019-2020)
Table 42. Europe Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Genitourinary Drugs Market Share by Type (2015-2020)
Table 44. Europe Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Genitourinary Drugs Market Share by Application (2015-2020)
Table 46. China Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 47. China Key Players Genitourinary Drugs Market Share (2019-2020)
Table 48. China Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. China Genitourinary Drugs Market Share by Type (2015-2020)
Table 50. China Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. China Genitourinary Drugs Market Share by Application (2015-2020)
Table 52. Japan Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Genitourinary Drugs Market Share (2019-2020)
Table 54. Japan Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Genitourinary Drugs Market Share by Type (2015-2020)
Table 56. Japan Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Genitourinary Drugs Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Genitourinary Drugs Market Share (2019-2020)
Table 60. Southeast Asia Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Genitourinary Drugs Market Share by Type (2015-2020)
Table 62. Southeast Asia Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Genitourinary Drugs Market Share by Application (2015-2020)
Table 64. India Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 65. India Key Players Genitourinary Drugs Market Share (2019-2020)
Table 66. India Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. India Genitourinary Drugs Market Share by Type (2015-2020)
Table 68. India Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. India Genitourinary Drugs Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Genitourinary Drugs Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Genitourinary Drugs Market Share (2019-2020)
Table 72. Central & South America Genitourinary Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Genitourinary Drugs Market Share by Type (2015-2020)
Table 74. Central & South America Genitourinary Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Genitourinary Drugs Market Share by Application (2015-2020)
Table 76. Novartis AG Company Details
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Product
Table 79. Novartis AG Revenue in Genitourinary Drugs Business (2015-2020) (Million US$)
Table 80. Novartis AG Recent Development
Table 81. Genentech Company Details
Table 82. Genentech Business Overview
Table 83. Genentech Product
Table 84. Genentech Revenue in Genitourinary Drugs Business (2015-2020) (Million US$)
Table 85. Genentech Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genitourinary Drugs Market Share by Type: 2020 VS 2026
Figure 2. Urologicals Features
Figure 3. Hormonal Therapy Features
Figure 4. Gynecological Features
Figure 5. Anti-infectives Features
Figure 6. Global Genitourinary Drugs Market Share by Application: 2020 VS 2026
Figure 7. Prostate Cancer Case Studies
Figure 8. Ovarian Cancer Case Studies
Figure 9. Bladder Cancer Case Studies
Figure 10. Cervical Cancer Case Studies
Figure 11. Renal Cancer Case Studies
Figure 12. Erectile Dysfunction Case Studies
Figure 13. Urinary Tract Infections Case Studies
Figure 14. Urinary Incontinence & Overactive Bladder Case Studies
Figure 15. Sexually Transmitted Diseases Case Studies
Figure 16. Genitourinary Drugs Report Years Considered
Figure 17. Global Genitourinary Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Genitourinary Drugs Market Share by Regions: 2020 VS 2026
Figure 19. Global Genitourinary Drugs Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Genitourinary Drugs Market Share by Players in 2019
Figure 22. Global Top Genitourinary Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genitourinary Drugs as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Genitourinary Drugs Revenue in 2019
Figure 24. North America Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Genitourinary Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed
  • Global Overactive Bladder Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Overactive Bladder Treatment market size was valued at US$ 4989.1 million in 2023. With growing demand in downstream market, the Overactive Bladder Treatment is forecast to a readjusted size of US$ 6182.8 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Overactive Bladder Treatment market. Overactive Bladder Treatment are expected to show stable growth......
  • Global Genitourinary Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 110
    Market Overview of Global Genitourinary Drugs market: According to our latest research, the global Genitourinary Drugs market looks promising in the next 5 years. As of 2022, the global Genitourinary Drugs market was estimated at USD 30442.38 million, and it's anticipated to reach USD 32574.96 million in 2028, with a CAGR of 1.13% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Urinary Tract Infection Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Urinary Tract Infection Treatment market: According to our latest research, the global Urinary Tract Infection Treatment market looks promising in the next 5 years. As of 2022, the global Urinary Tract Infection Treatment market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. A urinary tract infection is an infection that can occur in any area of the urinary tract, i......
  • Global Overactive Bladder Treatment Market Research Report 2023, Forecast to 2028
    Published: 02-Nov-2023        Price: US 2680 Onwards        Pages: 130
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Overactive Bladder Treatment Professional Survey Report 2023, Forecast to 2028
    Published: 02-Nov-2023        Price: US 3280 Onwards        Pages: 103
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Overactive Bladder Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 17-Oct-2023        Price: US 3380 Onwards        Pages: 105
    Market Overview of Global Overactive Bladder Treatment market: According to our latest research, the global Overactive Bladder Treatment market looks promising in the next 5 years. As of 2022, the global Overactive Bladder Treatment market was estimated at USD 3983.87 million, and it's anticipated to reach USD 5304.63 million in 2028, with a CAGR of 4.89% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......
  • Genitourinary Collaboration and Licensing Deals 2016-2023
    Published: 01-Oct-2023        Price: US 3995 Onwards        Pages: 150
    Genitourinary Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the genitourinary deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of genitourinary deals from 2016 to 2023. The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms. Underst......
  • Global Genitourinary Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 70
    The global Genitourinary Drugs market is projected to grow from US$ 29570 million in 2023 to US$ 35930 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period. The US & Canada market for Genitourinary Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Genitourinary Drugs is estimated to increase from $ million in 202......
  • Global Overactive Bladder Therapeutics Market Insights, Forecast to 2029
    Published: 28-Jun-2023        Price: US 4900 Onwards        Pages: 88
    Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device. Market Analysis and Insights: Global Overactive Bladder Therapeutics Market The global Overactive Bladder Therapeutics market is projected to grow from US$ 5240.8 million in 2023 t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs